JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McDOUGAL, B.
Right arrow Articles by SULLIVAN, L. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McDOUGAL, B.
Right arrow Articles by SULLIVAN, L. P.
Journal of Pharmacology And Experimental Therapeutics, Vol. 172, Issue 2, 203-210, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


STUDIES OF THE EFFECT OF BENDROFLUMETHIAZIDE ON SODIUM TRANSPORT AND METABOLISM IN THE TOAD BLADDER

BARBARA McDOUGAL 1 and LAWRENCE P. SULLIVAN 1

1 Department of Physiology, University of Kansas Medical Center, Kansas City, Kansas

The effect of bendroflumethiazide (BHFT) on the metabolic processes supporting transepithelial Na transport in the isolated toad bladder has been studied. The thiazide inhibited short-circuit current (SCC) in bladders depleted of endogenous glycogen, inhibited stimulation of SCC by glucose and pyruvate and inhibited SCC supported solely by anaerobic metabolism. The drug does not interfere with glycolysis since it increases lactate accumulation. BHFT, however, did depress O2 consumption. The effect on lactate accumulation and O2 consumption also occurred in the absence of Na indicating that the drug has a direct effect on metabolism and may not directly affect the Na transport mechanism. Ouabain, which depresses lactate accumulation and inhibits NaK-activated adenosine triphosphatase, caused the same fractional inhibition of SCC in bladders pretreated with BHFT as in control bladders indicating that the effects of these two inhibitors are quite different. The effects of BHFT and fluoroacetate, an inhibitor of the tricarboxylic acid cycle, on SCC were also additive. The data suggest that BHFT depresses Na transport in the toad bladder by interfering with a step linking glycolysis and aerobic metabolism to Na transport. Interference with this step inhibits aerobic metabolism whether Na is present or absent but does not affect glycolysis.

Submitted on August 26, 1969
Accepted on November 20, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.